ESTRO37_ProgrammeBook

HONORARY MEMBER

Joachim Yahalom Memorial Sloan Kettering Cancer Center New York, USA

Dr Joachim (Achy) Yahalom is the founder and Chairman of the International Radiation Oncology Group (ILROG). ILROG currently engages over 1100 active members in 56 countries. He is Member and Professor of Radiation Oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) and Cornell University, respectively. He co-chairs of the lymphoma Disease Management Team at MSKCC. He earned his medical degree at the Hebrew University-Hadassah School of medicine in Jerusalem, Israel. After completion of training in Medicine and in Clinical and Radiation Oncology at Hadassah University Hospital in Jerusalem, he joined the faculty of MSKCC in 1985. His translation and clinical research focuses on the integration of radiotherapy into the modern management of hematological malignancies. Among his contributions: incorporation of RT into salvage programs of Hodgkin lymphoma and NHL, establishing limited RT alone as a curative approach for extra-nodal marginal zone lymphomas (MALT lymphomas), combined modality treatments of primary CNS lymphomas and reducing radiation exposure of normal tissues by incorporating PET imaging and IMRT into the new concepts of radiation field design. Other areas of his team’s research were autophagy as a mechanism of radiation-induced cell death and currently, the molecular signature of highly radiation-responsive or resistant follicular lymphomas. Radiotherapy triggering and enhancement the effect of new lymphoma therapies, particularly immune checkpoint inhibitors is the new focus of his group. Dr Yahalom has been instrumental in developing and disseminating the recent ILROG guidelines for several hematological malignancies lymphomas and is also a member of several NCCN guidelines committees.

Joachim Yahalom

ESTRO AWARDS | Programme and Exhibition Guide

42